Hydrochloric Acid

Hydrochloric Acid

SCHEMBL9491995

CCc1ccc(N)c(O)c1.Cl

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA known ✓ P10253 3/20 0.65
ADRA2A known ✓ P08913 1/20 0.41
DRD2 known ✓ P14416 1/20 0.41
DRD1 known ✓ P21728 1/20 0.41
DRD4 known ✓ P21917 1/20 0.41
SLC6A2 known ✓ P23975 1/20 0.41
DRD3 known ✓ P35462 1/20 0.41
SLC6A3 known ✓ Q01959 1/20 0.41
CA2 known ✓ P00918 1/20 0.38
KDM4E B2RXH2 3/20 0.65
MAPT P10636 3/20 0.65
POLB P06746 2/20 0.65
MEN1 O00255 1/20 0.65
RAB9A P51151 1/20 0.65
KMT2A Q03164 1/20 0.65
TRPA1 O75762 1/20 0.61
ALOX15 P16050 2/20 0.48
HSD17B10 Q99714 2/20 0.48
CYP3A4 P08684 1/20 0.48
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL31134106 1.00 KDM4E (0.65) KDM4EGAAMAPTPOLBMEN1
SCHEMBL29631753 0.98 POLB (0.68) KDM4EGAAMAPTPOLBMEN1
SCHEMBL454989 0.98 POLB (0.68) KDM4EGAAMAPTPOLBMEN1
SCHEMBL14645890 0.88 RAB9A (0.57) KDM4EGAAMAPTPOLBMEN1
Phosphoric Acid SCHEMBL5176868 0.88 GAA (0.57) KDM4EGAAMAPTPOLBMEN1
Hydrochloric Acid SCHEMBL11091223 0.83 TRPA1 (0.61) KDM4EGAAMAPTPOLBMEN1
Hydrochloric Acid SCHEMBL21173968 0.82 MAPT (0.95) KDM4EGAAMAPTPOLBMEN1
SCHEMBL2786932 0.81 KDM4E (0.63) KDM4EGAAMAPTPOLBMEN1
Hydrochloric Acid SCHEMBL3574208 0.80 MAPT (0.68) KDM4EGAAMAPTPOLBMEN1
SCHEMBL1025691 0.80 TRPA1 (0.64) KDM4EGAAMAPTPOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118084688-A Preparation method of 2-hydroxy-4-ethylaniline and hydrochloride thereof 浙江鼎龙科技股份有限公司 2024-05-28 CN claimed
CN-118063332-A Preparation method of 2-hydroxy-4-ethylaniline and hydrochloride thereof 浙江鼎龙科技股份有限公司 2024-05-24 CN claimed
CN-118063333-A Preparation method of 2-hydroxy-4-ethylaniline and hydrochloride thereof 浙江鼎龙科技股份有限公司 2024-05-24 CN claimed
US-20260137607-A1 COMPOSITION COMPRISING THE COMBINATION OF TWO PARTICULAR OXIDATION DYE PRECURSORS AND A FATTY ACID ESTER OF GLYCEROL LOREAL (FR) 2026-05-21 US disclosed
EP-4262720-B1 COMPOSITION COMPRISING TWO PARTICULAR OXIDATION DYE PRECURSORS, AND A PARTICULAR CARBOXYLIC ACID OREAL (FR) 2026-05-06 EP disclosed
EP-4262716-B1 COMPOSITION COMPRISING A PARTICULAR OXIDATION DYE PRECURSOR AND A PARTICULAR CARBOXYLIC ACID OREAL (FR) 2026-05-06 EP disclosed
US-12589063-B2 Composition comprising a combination of two particular oxidation dye precursors, an amphoteric or zwitterionic surfactant and a solid fatty substance L'OREAL (FR) 2026-03-31 US disclosed
US-12583876-B2 Branched organosilicon compound, method of preparing same, and related compositions DOW SILICONES CORPORATION (US) 2026-03-24 US disclosed
US-12569420-B2 Composition comprising a particular oxidation dyeing base and at least two particular couplers L'ORÉAL (FR) 2026-03-10 US disclosed
EP-4422582-B1 COMPOSITION COMPRISING THE COMBINATION OF TWO PARTICULAR OXIDATION DYE PRECURSORS AND A FATTY ACID ESTER OF GLYCEROL OREAL (FR) 2025-11-05 EP disclosed
EP-3493878-B1 COSMETIC COMPOSITION COMPRISING CURED SILICONE MATERIALS DOW SILICONES CORP (US) 2025-10-08 EP disclosed
US-20160184214-A1 COSMETIC COMPOSITIONS CONTAINING SILICONES DOW CORNING CORPORATION (US) 2016-06-30 US disclosed
US-20150322097-A1 PROCESS FOR PREPARING AN ORGANOSILANE COMPOSITION DOW SILICONES CORPORATION 2015-11-12 US disclosed
CN-104769092-A Fabric care compositions comprising emulsions DOW CORNING 2015-07-08 CN disclosed
US-20140127140-A1 Cosmetic Composition Comprising Hydrophilic Organosilanes DOW CORNING CORPORATION (US) 2014-05-08 US disclosed
CN-103491937-A Oxidative dyeing composition comprising 1-hexyl/heptyl-4, 5-diaminopyrazole and 2-aminophenol and derivatives thereof PROCTER & GAMBLE 2014-01-01 CN disclosed
US-20130336909-A1 PERSONAL CARE AND HEALTH CARE COMPOSITIONS DOW CORNING CORPORATION (US) 2013-12-19 US disclosed
US-8444709-B2 Oxidative dyeing compositions comprising an 1-hexyl/heptyl-4,5-diaminopyrazole and a 2-aminophenol and derivatives thereof THE PROCTER & GAMBLE COMPANY (US) 2013-05-21 US disclosed
US-20120210519-A1 Oxidative Dyeing Compositions Comprising an 1-Hexyl/Heptyl-4,5-diaminopyrazole and a 2-Aminophenol and Derivatives Thereof WELLA OPERATIONS US, LLC 2012-08-23 US disclosed
US-5214194-A Preparation of 5-substituted 2-aminophenols, reaction of nitrone with trichloroacetyl chloride EASTMAN KODAK COMPANY (US) 1993-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12589063-B2 Composition comprising a combination of two particular oxidation dye precursors, an amphoteric or zwitterionic surfactant and a solid fatty substance S100P, KRT18, S100A4 GAA 4691/4885ADRA2A 2791/4885DRD2 2634/4885
US-20120210519-A1 Oxidative Dyeing Compositions Comprising an 1-Hexyl/Heptyl-4,5-diaminopyrazole and a 2-Aminophenol and Derivatives Thereof TYR, GPX4, TH GAA 4087/4885ADRA2A 1674/4885DRD2 770/4885
US-12569420-B2 Composition comprising a particular oxidation dyeing base and at least two particular couplers KRT18, COL1A1, S100P GAA 4826/4885ADRA2A 2116/4885DRD2 1154/4885
US-20260137607-A1 COMPOSITION COMPRISING THE COMBINATION OF TWO PARTICULAR OXIDATION DYE PRECURSORS AND A FATTY ACID ESTER OF GLYCEROL KRT18, FABP4, HSD17B4 GAA 3169/4885ADRA2A 355/4885DRD2 870/4885
US-12583876-B2 Branched organosilicon compound, method of preparing same, and related compositions OXSR1, BRS3, NPSR1 GAA 4501/4885ADRA2A 817/4885DRD2 1021/4885
US-20150322097-A1 PROCESS FOR PREPARING AN ORGANOSILANE COMPOSITION BRS3, HRH3, H1-3 GAA 4628/4885ADRA2A 1640/4885DRD2 2477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.